Inadäquate Schocks bei Patienten mit implantierbarem Kardioverter-Defibrillator

In der vorliegenden Arbeit wurden die Inzidenz und die Ursachen inadäquater Schocks bei Patienten mit implantierbarem Kardioverter-Defibrillator evaluiert. Dazu wurden 557 Patienten konsekutiv in dem Marburger Defibrillator-Datenregister erfasst und über einen Zeitraum von 50 ± 37 Monaten nachbeobac...

Full description

Saved in:
Bibliographic Details
Main Author: Gebhardt, Sonja
Contributors: Grimm, Wolfram (Prof. Dr.) (Thesis advisor)
Format: Dissertation
Language:German
Published: Philipps-Universität Marburg 2011
Innere Medizin
Subjects:
Online Access:PDF Full Text
Tags: Add Tag
No Tags, Be the first to tag this record!

1. Swerdlow CD, Gunderson BD, Ousdigian KT, Abeyratne A, Stadler RW, Gillberg JM, Patel AS, Ellenbogen KA. Downloadable algorithm to reduce inappropriate shocks caused by fractures of implantable cardioverter-defibrillator leads. Circulation. Nov 2008;118(21):2122-2129.


2. Wathen MS, Sweeney MO, DeGroot PJ, Stark AJ, Koehler JL, Chisner MB, Machado C, Adkisson WO, PainFREE Investigators. Shock reduction using antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with coronary artery disease. Circulation. Aug 2001;104(7):796-801.


3. Tzeis S, Andrikopoulos G, Kolb C, Vardas PE. Tools and strategies for the reduction of inappropriate implantable cardioverter defibrillator shocks. Europace. Nov 2008;10(11):1256-1265.


4. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, AMIOVIRT Investigators. Amiodarone versus implantable cardioverter- defibrillator:randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia--AMIOVIRT. J Am Coll Cardiol. May 2003;41(10):1707-1712.


5. Klein RC, Raitt MH, Wilkoff BL, Beckman KJ, Coromilas J, Wyse DG, Friedman PL, Martins JB, Epstein AE, Hallstrom AP, Ledingham RB, Belco KM, Greene HL. Analysis of implantable cardioverter defibrillator therapy in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial. J Cardiovasc Electrophysiol. Sep 2003;14(9):940-948.


6. Sweeney MO, Wathen MS, Volosin K, Abdalla I, DeGroot PJ, Otterness MF, Stark AJ. Appropriate and inappropriate ventricular therapies, quality of life, and mortality among primary and secondary prevention implantable cardioverter defibrillator patients: results from the Pacing Fast VT REduces Shock ThErapies (PainFREE Rx II) trial. Circulation. Jun 2005;111(22):2898-2905.


7. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH, Defibrillators in Non- Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med. May 2004;350(21):2151-2158.


8. Lee CH, Nam GB, Park HG, Kim HY, Park KM, Kim J, Choi KJ, Kim YH. Effects of antiarrhythmic drugs on inappropriate shocks in patients with implantable cardioverter defibrillators. Circ J. Jan 2008;72(1):102-105.


9. Veltmann C, Borggrefe M, Schimpf R, Wolpert C. Fatal inappropriate ICD shock. J Cardiovasc Electrophysiol. Mar 2007;18(3):326-328.


10. Kallinen LM, Hauser RG, Tang C, Melby DP, Almquist AK, Katsiyiannis WT, Gornick CC Lead integrity alert algorithm decreases inappropriate shocks in patients who have Sprint Fidelis pace-sense conductor fractures. Heart Rhythm. Aug 2010;7(8):1048- 1055.


11. Spragg D, Berger R. How to avoid inappropriate shocks. Heart Rhythm. May 2008;5(5):762-765.


12. Moss AJ, Hall WJ, Cannom DS, Daubert JP, Higgins SL, Klein H, Levine JH, Saksena S, Waldo AL, Wilber D, Brown MW, Heo M. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med. Dec 1996;335(26):1933-1940.


13. Weber M, Block M, Brunn J, Bänsch D, Böcker D, Hammel D, Gietzen F, Breithardt G. [Inadequate therapies with implantable cardioverter-defibrillators--incidence, etiology, predictive factors and preventive strategies]. Z Kardiol. Nov 1996;85(11):809-819.


14. Kreuz J, Balta O, Liliegren N, Mellert F, Esmailzadeh B, Nickenig G, Schwab JO. Incidence and characteristics of appropriate and inappropriate therapies in recipients of ICD implanted for primary prevention of sudden cardiac death. Pacing Clin Electrophysiol. Jan 2007;30 Suppl 1:S125-127.


15. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival from out-of- hospital cardiac arrest: a graphic model. Ann Emerg Med. Nov 1993;22(11):1652-1658.


16. Sears SF, Lewis TS, Kuhl EA, Conti JB. Predictors of quality of life in patients with implantable cardioverter defibrillators. Psychosomatics. 2005 Sep-Oct 2005;46(5):451- 457.


17. Theuns D, Klootwijk A, Goedhart D, Jordaens L. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms. J Am Coll Cardiol. Dec 2004;44(12):2362-2367.


18. Kowalski M, Huizar JF, Kaszala K, Wood MA. Problems with implantable cardiac device therapy. Cardiol Clin. Aug 2008;26(3):441-458, vii.


19. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation. Oct 2004;110(17):2591-2596.


20. Schron EB, Exner DV, Yao Q, Jenkins LS, Steinberg JS, Cook JR, Kutalek SP, Friedman PL, Bubien RS, Page RL, Powell J. Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks. Circulation. Feb 2002;105(5):589-594.


21. Kuck K, Cappato R, Siebels J, Rüppel R. Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest : the Cardiac Arrest Study Hamburg (CASH). Circulation. Aug 2000;102(7):748-754.


22. Morrison TB, Rea RF, Hodge DO, Crusan D, Koestler C, Asirvatham SJ, Bradley D, Shen WK, Munger TM, Hammill SC, Friedman PA. Risk factors for implantable defibrillator lead fracture in a recalled and a nonrecalled lead. J Cardiovasc Electrophysiol. Jun 2010;21(6):671-677.


23. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK. Strategic programming of detection and therapy parameters in implantable cardioverter- defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol. Aug 2008;52(7):541-550.


24. Mark DB, Anstrom KJ, Sun JL, Clapp-Channing NE, Tsiatis AA, Davidson-Ray L, Lee KL, Bardy GH, Sudden Cardiac Death in Heart Failure Trial Investigators. Quality of life with defibrillator therapy or amiodarone in heart failure. N Engl J Med. Sep 2008;359(10):999-1008.


25. Zheng Z, Croft J, Giles W, Mensah G. Sudden cardiac death in the United States, 1989 to 1998. Circulation. Oct 2001;104(18):2158-2163.


26. Sweeney MO. The contradiction of appropriate shocks in primary prevention ICDs: increasing and decreasing the risk of death. Circulation. Dec 2010;122(25):2638-2641.


27. Van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ. Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol. Feb 2011;57(5):556-562.


28. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. Mar 2002;346(12):877-883.